Patents by Inventor Elizabeth A. Woolf

Elizabeth A. Woolf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040229316
    Abstract: The present invention relates to the discovery, identification and characterization of nucleic acids that encode a novel G protein coupled receptor (I5E) protein. The invention encompasses I5E nucleotides, host cell expression systems, I5E proteins, fusion proteins, polypeptides and peptides, antibodies to the receptor., transgenic animals that express an I5E transgene, or recombinant knock-out animals that do not express the I5E, antagonists and agonists of the receptor, and other compounds that modulate I5E gene expression or I5E activity that can be used for diagnosis, drug screening, clinical trial monitoring, and/or used to treat disorders such as inflammatory, central nervous system or gastrointestinal disorders.
    Type: Application
    Filed: May 13, 2004
    Publication date: November 18, 2004
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Karen Moore, Deborah Lynn Nagle, Elizabeth A. Woolf
  • Patent number: 5891720
    Abstract: The present invention relates to the discovery, identification and characterization of nucleic acids that encode a novel G protein coupled receptor (I5E) protein. The invention encompasses I5E nucleotides, host cell expression systems, I5E proteins, fusion proteins, polypeptides and peptides, antibodies to the receptor, transgenic animals that express an I5E transgene, or recombinant knock-out animals that do not express the I5E, antagonists and agonists of the receptor, and other compounds that modulate I5E gene expression or I5E activity that can be used for diagnosis, drug screening, clinical trial monitoring, and/or used to treat disorders such as inflammatory, central nervous system or gastrointestinal disorders.
    Type: Grant
    Filed: April 17, 1997
    Date of Patent: April 6, 1999
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Karen Moore, Deborah Lynn Nagle, Elizabeth A. Woolf